Stanford University
Showing 841-850 of 2,645 Results
-
Yan Chang
Ph.D. Student in Japanese, admitted Autumn 2021
BioYan Chang is a Ph.D. student in modern and contemporary East Asian literatures, cultures, and media. His research interests currently center on trans-linguality, trans-culture, and trans-nationality in post-Cold War Japanophone literature. His academic concerns also include visuality and modernity of modern Japanese literature in the Taisho period as well as Shanghai urbanization and the concomitant media representations in the 1990s. Before joining Stanford, Yan received a joint B.A. in Economics and Japanese from Shanghai International Studies University, an M.A. in Japanese Culture Studies from Nagoya University, and an M.A. in Asian and Middle Eastern Studies from the University of Minnesota at Twin Cities.
-
Yihe M. Chang
Undergraduate, Economics
Research Assistant, SIEPR OperationsBioAn aspiring economist focusing on international development; a passionate organist and choral conductor.
-
Ying Chih Chang
Adjunct Professor, Chemical Engineering
BioDr. Ying Chang is the Chair of the Taiwan Science and Technology Hub and an Adjunct Professor in the Department of Chemical Engineering at Stanford University. She is also the Founder and CEO of Acrocyte Therapeutics, Inc.
Her former faculty appointments include Research Fellow (-Associate Fellow) at the Genomics Research Center, Academia Sinica, Taiwan, and Assistant Professor in the Departments of Chemical Engineering and Materials Science, and Biomedical Engineering at the University of California, Irvine. The research highlights include integrating nanomaterials, microfluidics, and bioreactors to control cell fates for tissue engineering, as well as developing circulating tumor cell 3D culture for cancer diagnostics and precision medicine. She holds multiple patents in DNA microarray constructs (assigned to Affymetrix), circulating tumor cell isolation and cancer screening (assigned to Cellmax Life Inc.), and single cell derived scaffold free 3D culture platform RCE and circulating tumor cell liquid biopsy drug test (assigned to Acrocyte Therapeutics Inc. www.acrocyte.com).
Dr. Chang’s work was recognized by the Young Investigator Award from the Whitaker Foundation, FDA breakthrough device designation for pre-cancer and cancer detection (2021), Future Tech Award (2021), 18th National Innovation Award, Taiwan (2021), and Finalist at Startup Stadium at BIO 2024, among other. She is also on the board of trustees of Kaohsiaung Medical University, and Chang Chau-Ting Memorial Foundation, a non-profit organization for science education and awareness in Taiwan. She received her BS from National Taiwan University, and PhD from Stanford University, both in Chemical Engineering.
